ULCERATIVE COLITIS CHRONIC MODERATE
Clinical trials for ULCERATIVE COLITIS CHRONIC MODERATE explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS CHRONIC MODERATE trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS CHRONIC MODERATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a probiotic tame ulcerative colitis? early trial begins
Disease control Recruiting nowThis early-stage study is testing whether an oral probiotic called R-3750 is safe and tolerable for people with mild to moderate ulcerative colitis. About 36 adults will take the probiotic and be monitored for side effects, inflammation, and symptom changes. The goal is to see if…
Matched conditions: ULCERATIVE COLITIS CHRONIC MODERATE
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for severe colitis: experimental drug BRS201 enters human trial
Disease control Recruiting nowThis study tests a new oral drug called BRS201 in 20 adults with severe ulcerative colitis who have not improved with standard treatments. Participants take the drug twice daily for 4 weeks and attend 8 clinic visits for blood, stool, and urine tests. The goal is to see if BRS201…
Matched conditions: ULCERATIVE COLITIS CHRONIC MODERATE
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC